share_log
Reuters ·  05:30
Knight Therapeutics Announces Filing of New Drug Submission for Qelbree® (Viloxazine) in Canada
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment